Wedmont Private Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $391K | Sell |
707
-66
| -9% | -$36.5K | 0.02% | 494 |
|
|
2025
Q1 | $428K | Sell |
773
-934
| -55% | -$518K | 0.02% | 423 |
|
|
2024
Q4 | $1.19M | Buy |
1,707
+211
| +14% | +$147K | 0.06% | 189 |
|
|
2024
Q3 | $1.49M | Buy |
1,496
+65
| +5% | +$64.7K | 0.09% | 143 |
|
|
2024
Q2 | $1.57M | Buy |
1,431
+8
| +0.6% | +$8.8K | 0.1% | 123 |
|
|
2024
Q1 | $1.34M | Buy |
1,423
+233
| +20% | +$220K | 0.1% | 137 |
|
|
2023
Q4 | $1.07M | Buy |
1,190
+141
| +13% | +$127K | 0.09% | 148 |
|
|
2023
Q3 | $873K | Buy |
1,049
+172
| +20% | +$143K | 0.09% | 150 |
|
|
2023
Q2 | $630K | Sell |
877
-124
| -12% | -$89.1K | 0.07% | 199 |
|
|
2023
Q1 | $825K | Buy |
1,001
+214
| +27% | +$176K | 0.11% | 135 |
|
|
2022
Q4 | $580K | Buy |
787
+65
| +9% | +$47.9K | 0.09% | 178 |
|
|
2022
Q3 | $497K | Buy |
722
+187
| +35% | +$129K | 0.1% | 164 |
|
|
2022
Q2 | $316K | Buy |
535
+38
| +8% | +$22.4K | 0.07% | 224 |
|
|
2022
Q1 | $347K | Buy |
497
+149
| +43% | +$104K | 0.08% | 206 |
|
|
2021
Q4 | $214K | Buy |
+348
| New | +$214K | 0.07% | 223 |
|